PSMD3 and acute myeloid leukemia: Consistent with an oncogenic role for PSMD3 in AML, mice receiving shPSMD3-expressing cells had a significant increase in OS compared with mice receiving the shNT-expressing control cells (p = 0.0027, Figure 3).